| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Scinai Immunotherapeutics Ltd.
13G/A
09073Q203
|
9.9% |
7/1/2026
Event 6/4/2026
|
||||
| Stone Daniel E. | 9.9% | |||||
| RK Stone Miami, LLC | 7.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.